Please login or register to print this page.

VIEW TAGS

Articles tagged ‘cost-effectiveness’

October 31, 2014

Thumb-based ECG detects silent AF in stroke patients

Regular screening using a handheld electrocardiology (ECG) device on 75-year-old stroke patients for detecting silent atrial fibrillation (AF) is both effective and provides long-term cost savings, according to a new clinical study published in Europace.1

read more

August 5, 2014

Apixaban cost-effective in stroke prevention

Based on randomised trial data, apixaban is a cost-effective alternative to warfarin and aspirin, in vitamin K antagonists (VKA) suitable and VKA unsuitable patients with AF, respectively, according to a recent study.1

read more

April 26, 2013

Are NOACs more cost-effective than warfarin?

In patients with nonvalvular atrial fibrillation (AF) and an increased risk of stroke prophylaxis, apixaban 5 mg, dabigatran 150 mg, and rivaroxaban 20 mg are all cost-effective alternatives to warfarin, according to a study1 published recently in Stroke.

read more

August 2, 2011

DABIGATRAN – COST EFFECTIVE?

The superiority of dabigatran to warfarin, as reported by the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial, may be offset by its cost, according to an editorial1 published recently in Circulation.

read more

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.